Rubicon Research's ANDA220869 for Promethazine and Dextromethorphan Receives AP Status
The FDA has granted an Abbreviated New Drug Application (ANDA) approval status to Rubicon Research for a combination of Promethazine Hydrochloride and Dextromethorphan Hydrobromide.